Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent

Cellular and Molecular Neurobiology

Volumn 22, Issue 4, 2002, Pages 445-454

  Cabrera, Ricardo J ^a   Bregonzio, Claudia ^a   Laconi, Myriam ^a   Mampel, Alejandra ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Allopregnanolone; Dopamine; N methyl D aspartic acid; Ovarian hormones; Striatum

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTROGEN; N METHYL DEXTRO ASPARTIC ACID; NEUROSTEROID; PROGESTERONE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; ESTRUS; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESTROGENS; FEMALE; N-METHYLASPARTATE; OVARIECTOMY; PREGNANOLONE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

ANIMALIA;

EID: 0036704969     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021015705597     Document Type: Article

References (33)

1. Becker, J. B., and Rudick, C. N. (1999). Rapid effects of estrogen or progesterone on the amphetamine induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study. Pharmacol. Biochem. Behav. 64:53-57.
2. 3H-norepinephrine efflux from rat cortical slices during the estrus cycle. Neuroendocrinolgy 68:264-271.
3. Cabrera, R. J., and Bregonzio, C. (1996). Turnover rate and stimulus-evoked release of dopamine by progesterone and N-methyl-D-aspartic acid in rat striatum during pregnancy. Eur. J. Pharmacol. 317:55-59.
4. 3H-dopamine release from rat corpus striatum slices obtained under different endocrine conditions. Life Sci. 53:1767-1777.
5. 3H-dopamine release from striatal slices in proestrus rats. Neuropharmacology 35:175-178.
6. Caligaris, L., Astrada, J. J., Taleisnik, S. (1972). Effect of oestrogen and progesterome on the release of luteinizing harmone in pseudo pregnant rats. Acta. Endocrinol. 70: 163-6.
7. Campagnone, N. A., and Mellon, S. H. (2000). Neurosteroids: Biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21:1-56.
8. Concas, A., Follesa, P., Barbaccia, M. L., Purdy, R. H., and Biggio, G. (1999). Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur. J. Pharmacol. 375:225-235.
9. Copérchot, C., Young, J., Cavel, M., Wehrey, C., Veltz, J. N., Touyer, G., Mouren, M., Prasad, V. V., Banner, C., Sjovall, J., Baulieu, E. E., and Robel, P. (1993). Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133:1003-1009.
10. García-Segura, L. M., Chowen, J. A., and Naftolin, F. (1996). Endocrine glia: Roles of glial cells in the brain actions of steroids and thyroids hormones and in the regulation of hormone secretion. Front. Neuroendocrinology 17:180-211.
11. Genazzani, A. R., Stomati, M., Morittu, A., Bernardi, F., Monteleone, P., Casarosa, E., Gallo, R., Salvestroni, C., and Luisi, M. (2000). Progesterone, progestagens and the central nervous system. Hum. Reprod. 15:14-27.
12. Kompoliti, K., Comella, C. L., Jaglin, J. A., Leurgans, S., Raman, R., and Goetz, C. G. (2000). Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology 55(10):1572-1575.
13. Krebs, M. O., Desce, J. M., Kernel, M. L., Gauchi, C., Godeheu, G., Cheramy, A., and Glowisnki, J. (1991). Glutamatergic control of dopamine release in rat striatum: Evidence for presynaptic aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:81-85.
14. Kretschmer, B. D. (1999). Modulation of the mesolimbic dopamine system by glutamate: Role of NMDA receptors. J. Neurochem. 73:839-848.
15. Lan, N. C., Gee, K., Bolger, M. B., and Chen, J. S. (1991). Differential responses of expressed combinant human GABA receptors to neurosteroids. J. Neurochem. 57:1818-1821.
16. Mahesh, V. B., Brann, D. W., and Hendry, L. B. (1996). Diverse modes of action of progesterone and its metabolites. J. Steroid Biochem. Mol. Biol. 56:209-219.
17. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:379-395.
18. Mc Ewen, B. S. (1991). Non-genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:141-147.
19. Meyer, J. H., and Gruol, D. L. (1994). Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice. Brain Res. 633:253-261.
20. Minami, T., Oomura, Y., Nabekura, J., and Fukuda, A. (1990). 17-β-Estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res. 519:301-307.
21. Mizuta, E., Yamasaki, S., Nakatake, M., and Kuno, S. (1993). Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology 43(5):1048-1049.
22. Morari, M., Marti, M., Sbrenna, S., Fuxe, K., and Beani, L. (1998). Reciprocal dopamine-glutamate modulation of release in the basal ganglia. it Neurochem. Int. 33:383-397.
23. Quinn, N. P., and Marsden, C. D. (1986). Menstrual-related fluctuations in Parkinson's disease. Mov. Disord. 1(1):85-87.
24. Ramírez, V. D., Dluzen, D. E., and Ke, F. C. (1990). Steroid and neuronal activity. In Chadwick, D., Widdows, K. (eds.), Ciba Foundation Symposium 153, Wiley, New York, pp. 125-144.
25. Revelli, A., Tesarik, J., and Massobrio, M. (1998). Nongenomic effects of neurosteroids. Gynecol. Endocrinol. 12:61-67.
26. Roberts, E. (1995). Pregnenolone from Selye to Alzheimer and a model of pregnenolone sulfate binding site on GABA A receptor. Biochem. Pharmacol. 6:49, 1-16.
27. Ruprecht, R. (1996). Neurosteroids: Molecular mechanism of action and psychopharmacological significance. J. Steroid Biochem. Mol. Biol. 56:163-168.
28. Selye, H. (1942). Correlations between the chemical structure and pharmacological actions of steroids. Endocrinology 30:437-453.
29. Spindler, K. D. (1997). Interactions between steroid hormones and the nervous system. Neurotoxicolgy 18:745-754.
30. Strijks, E., Kremer, J. A., and Horstink, M. W. (1999). Effects of female sex steroids on Parkinson's disease in postmenopausal women. Clin. Neuropharmacol. 22(2):93-97.
31. Westerink, B. H., Santiago, M., and De Vries, J. B. (1992). The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the concious rat. Arch. Pharmacol. 345:523-529.
32. Wu, F. S., Gibbs, T. T., and Farb, D. H. (1991). Pregnenolone sulfate: A positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40:333-336.
33. Zwain, I. H., and Yen, S. S. (1999). Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140:3843-3852.